Blog

Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today provided

UDR, Inc. (the “Company”) (NYSE: UDR), a leading multifamily real estate investment trust and GRESB 5 Star rated company for its sustainability leadership, announced today that it has been named

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced 2023

DexCom, Inc. (Nasdaq: DXCM), the leader in real-time continuous glucose monitoring (“CGM”), today reported that it expects preliminary, unaudited revenue for the fourth quarter ended December 31

NICE (Nasdaq: NICE) today announced new RPA (Robotic Process Automation) capabilities in its latest release, using AI to identify focused opportunities for automation. With NEVA Discover’s new

DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the appointment of Teri Lawver to the newly created role of chief

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today

VICI Properties Inc. (NYSE: VICI) (“VICI Properties” or “VICI”), an experiential real estate investment trust, announced today that it has acquired the real estate assets of PURE Casino Edmonton in

Novocure (NASDAQ: NVCR) today reported preliminary unaudited financial results and operational updates for the quarter and full year ended December 31, 2022. Novocure is a global oncology company

QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) today announced it has completed the acquisition of Verogen, a leader in the use of next-generation sequencing (NGS) technologies to drive the

IMV Inc. (Nasdaq: IMV; TSX: IMV) (“IMV” or the “Company”), a clinical-stage biopharmaceutical company developing a portfolio of immune-educating therapies based on its novel DPX^® platform to treat

UBS Investment Bank today announced coupon payments for 12 ETRACS Exchange Traded Notes (the “ETNs”), all traded on the NYSE Arca.

NYSE Ticker

ETN Name and

Prospectus Supplement*

Cou

Essex Property Trust, Inc. (NYSE:ESS) announced today that it plans to release its fourth quarter 2022 earnings after the market closes on Tuesday, February 7, 2023. A conference call with senior

QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and

ROYAL GOLD, INC. (NASDAQ: RGLD) (together with its subsidiaries, “Royal Gold” or the “Company,” “we” or “our”) announced today that management will present in the live Virtual Non-Deal Roadshow

Regulatory News:

Lysogene (FR0013233475 – LYS) (Paris:LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, announces that it has requested, jointly with

Blackline Safety Corp. ("Blackline" or the "Company") (TSX: BLN), a global leader in connected safety technology, today announced it will release fiscal fourth quarter 2022 financial results before

First Business Financial Services, Inc. (the “Company”, the “Bank”, or “First Business Bank”) (Nasdaq:FBIZ) announced promotions among its commercial banking team, advancing key leaders across its

HCLTech, a leading global technology company, today announced that The ODP Corporation (“ODP”) (NASDAQ:ODP), a leading provider of products, services and technology solutions through an integrated

Comcast Corporation today announced Jason S. Armstrong has been promoted to Chief Financial Officer. Armstrong elevates to the position after serving nine years in several financial leadership

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to

Agilent Technologies, Inc. (NYSE: A) today announced a partnership with Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, to develop multiplex-immunohistochemistry diagnostic

Wells Fargo & Company (NYSE: WFC), as previously announced, will report its fourth quarter 2022 earnings results on Friday, Jan. 13, 2023, at approximately 7:00 a.m. Eastern time. The results will

Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted for priority review a supplemental Biologics License Application (sBLA) for its 20-valent

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today provided an update on its business performance. Preliminary unaudited net revenue for the three months and full year ended